EDGAR Filing Documents for 0001493152-23-012542

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001493152-23-012542

Filing Date

2023-04-17

Accepted

2023-04-17 16:16:07

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-k.htm iXBRL	10-K	2282040
2		ex4-3.htm	EX-4.3	25366
3		ex21.htm	EX-21	2423
4		ex23-1.htm	EX-23.1	6251
5		ex31-1.htm	EX-31.1	17162
6		ex31-2.htm	EX-31.2	17793
7		ex32.htm	EX-32	8317
8		form10-k_001.jpg	GRAPHIC	14584
	Complete submission text file	0001493152-23-012542.txt		9813530

Data Files

Seq	Description	Document	Type	Size
9	XBRL SCHEMA FILE	rspi-20221231.xsd	EX-101.SCH	72648
10	XBRL CALCULATION FILE	rspi-20221231_cal.xml	EX-101.CAL	49354
11	XBRL DEFINITION FILE	rspi-20221231_def.xml	EX-101.DEF	306557
12	XBRL LABEL FILE	rspi-20221231_lab.xml	EX-101.LAB	526035
13	XBRL PRESENTATION FILE	rspi-20221231_pre.xml	EX-101.PRE	382026
61	EXTRACTED XBRL INSTANCE DOCUMENT	form10-k_htm.xml	XML	1808768

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452

Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947

RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)